MBX
NASDAQ · Pharmaceuticals
Mbx Biosciences Inc
$43.03
+1.44 (+3.46%)
Open$42.84
Previous Close$41.59
Day High$43.49
Day Low$40.77
52W High$45.85
52W Low$9.43
Volume—
Avg Volume1.14M
Market Cap2.05B
P/E Ratio—
EPS$-2.21
SectorPharmaceuticals
Analyst Ratings
Strong Buy
16 analysts
Price Target
+9.5% upside
Current
$43.03
$43.03
Target
$47.13
$47.13
$32.34
$47.13 avg
$55.83
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 515.19M | 454.58M | 572.08M |
| Net Income | 92.27M | 88.31M | 111.14M |
| Profit Margin | 17.9% | 19.4% | 19.4% |
| EBITDA | 143.26M | 124.50M | 146.54M |
| Free Cash Flow | 88.64M | 54.29M | 70.53M |
| Rev Growth | +6.8% | +2.6% | +10.2% |
| Debt/Equity | 1.22 | 1.24 | 1.00 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |